Published in Vox Sang on January 01, 1985
Effects of helicopter transport on red blood cell components. Blood Transfus (2011) 0.75
Changes in immunoglobulin levels in severely burned patients. Lancet (1969) 1.53
Quantitative immunoglobulin determination. Comparison of two methods. Estimation of normal levels and levels in persons lacking IgA and IgD. Acta Pathol Microbiol Scand (1968) 1.51
Further studies on the effect of adenine in blood preservation. Transfusion (1967) 1.42
Divergent composition but similar function of soil food webs of individual plants: plant species and community effects. Ecology (2010) 1.29
The cellular and humoral immune response to Schistosoma mansoni infections in inbred rats. I. Mechanisms during initial exposure. Cell Immunol (1975) 1.11
Selective odor perception in the soil collembolaOnychiurus armatus. J Chem Ecol (1991) 1.02
Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang (2000) 0.95
Lack of conformity in the behaviour of platelets during normal storage conditions at 22 degrees C. Vox Sang (1981) 0.94
Clinical usefulness of red cells preserved in protein-poor mediums. N Engl J Med (1978) 0.94
The use of blood components in surgical transfusion therapy. World J Surg (1987) 0.93
Red cell suspensions in SAGM medium. Further experience of in vivo survival of red cells, clinical usefulness and plasma-saving effects. Vox Sang (1983) 0.92
Red cell preservation in protein-poor media. III. Protection against in vitro hemolysis. Vox Sang (1982) 0.91
Haemotherapy with red-cell concentrates and a new red-cell storage medium. Lancet (1983) 0.90
Drought acclimation and lipid composition in Folsomia candida: implications for cold shock, heat shock and acute desiccation stress. J Insect Physiol (2002) 0.90
Storage of buffy coat preparations at 22 degrees C in plastic containers with different gas permeability. Vox Sang (1997) 0.87
Serious bacterial complications from blood components--how do they occur? Transfus Med (1998) 0.85
HL-A haplotypes and unexplained infertility. Tissue Antigens (1972) 0.84
Hepatitis B antigen: removal from protein solutions in a recognizable form by an insoluble lipophilic matrix of silicic acid. Life Sci (1973) 0.83
Red blood cell preservation in protein-poor media. I. Leukocyte enzymes as a cause of hemolysis. Transfusion (1978) 0.82
A new apheresis procedure for the preparation of high-quality red cells and plasma. Transfusion (1999) 0.82
Computerized delivery control--a useful and safe complement to the type and screen compatibility testing. Vox Sang (1997) 0.82
Posttransfusion Serratia marcescens septicemia. Transfusion (1993) 0.81
Retrograde transmission of Proteus mirabilis during platelet transfusion and the use of arbitrarily primed polymerase chain reaction for bacteria typing in suspected cases of transfusion transmission of infection. Transfusion (1995) 0.81
Effects of oxygen on red cells during liquid storage at +4 degrees C. Vox Sang (1986) 0.80
Computer system for blood transfusion service. Transfusion (1970) 0.79
Simple method of improving the quality of platelet concentrates and the importance of production control. Transfusion (1978) 0.79
Transfusion-transmitted Yersinia enterocolitica infection. Protection through buffy coat removal and failure of the bacteria to grow in platelet-rich or platelet-poor plasma. Vox Sang (1993) 0.79
Frozen blood: a method for low-glycerol, liquid nitrogen freezing allowing different postthaw deglycerolization procedures. Transfusion (1974) 0.79
Distribution of blood gases, glucose and lactate within stored blood units. Vox Sang (1988) 0.78
Simple procedure for the removal of nonspecific inhibitors of rubella virus hemagglutination. J Clin Microbiol (1975) 0.78
Hormonal requirements for the uterine attachment reaction and blastocyst implantation in the mouse, hamster and guinea-pig. J Reprod Fertil (1971) 0.78
Attachment reaction of the uterine luminal epithelium at implantation: light and electron microscopy of the hamster, guinea-pig, rabbit and mink. J Reprod Fertil (1972) 0.77
A simple method for freezing of lymphocytes with retained viability. Vox Sang (1969) 0.77
A clinical evaluation of citrate-phosphate-dextrose-adenine blood. Vox Sang (1975) 0.77
Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood. Vox Sang (1998) 0.77
Studies on the mechanism of human red cell loss of viability during storage at +4 degrees C. II. Relation between cellular morphology and viability. Vox Sang (1987) 0.76
Which is the factual basis, in theory and clinical practice, for the use of fresh frozen plasma? Vox Sang (1978) 0.76
Preservation of red blood cells with purines and nucleosides. I. Changes of ATP, 2,3-P2G and further parameters of metabolism in red cells stored as whole blood and as resuspension at 4 degrees C and 25 degrees C. Folia Haematol Int Mag Klin Morphol Blutforsch (1980) 0.76
In vitro haemolysis of SAG-M and CPD-A blood units. Vox Sang (1985) 0.76
[Discrepancies in the statistics of HIV-positive persons should be corrected]. Lakartidningen (1993) 0.75
Autologous transfusions in uraemic patients. Lancet (1970) 0.75
The bottom and top system: a new technique for blood component preparation and storage. Vox Sang (1988) 0.75
Killing yersinia enterocolitica. J Clin Pathol (1996) 0.75
New trends in the preparation and storage of platelets. Transfusion (1992) 0.75
Yersinia enterocolitica and blood transfusion. Transfusion (1993) 0.75
The effect of blood transfusions on cadaver kidney transplants--an analysis of patients transplanted in Uppsala. Scand J Urol Nephrol Suppl (1977) 0.75
A simple method for the preparation of microaggregate-poor whole blood. Vox Sang (1981) 0.75
Purine metabolism of erythrocytes preserved in adenine, adenine-inosine, and adenine-guanosine supplemented media. Transfusion (1981) 0.75
The probability of donor-recipient histocompatibility in different HL-A phenotype combinations. Tissue Antigens (1971) 0.75
Pre-separation storage of whole blood: the effect of temperature on red cell 2,3-diphosphoglycerate and myeloperoxidase in plasma. Transfus Sci (1999) 0.75
Cell shape and total adenylate concentration as important factors for posttransfusion survival of erythrocytes. Biomed Biochim Acta (1983) 0.75
Additive system approach in blood transfusion: birth of the SAG and Sagman systems. Vox Sang (1986) 0.75
Blood preservation considering the possibilities, the patient and the purse. Acta Biol Med Ger (1981) 0.75
Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units. Comparison between three additive solutions: in vitro studies. Vox Sang (1995) 0.75
New trends in blood component therapy. Haematologia (Budap) (1983) 0.75
Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies. Vox Sang (1993) 0.75
Novel automated microbial screening of platelet concentrates. APMIS (1994) 0.75
A simple method for the standardization of centrifugation procedures in blood component preparation. Vox Sang (1982) 0.75
Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies. Vox Sang (1990) 0.75
A simple method for high-quality frozen red cells in blood group serology. Transfusion (1986) 0.75
Red blood cell preservation in protein-poor media. 2. Studies of changes in red cell shape during storage. Haematologia (Budap) (1980) 0.75
Complement killing of Yersinia enterocolitica and retention of the bacteria by leucocyte removal filters. Vox Sang (1994) 0.75
Rapid freezing of erythrocytes using glycerol in low concentrations. Bibl Haematol (1968) 0.75
To what extent can plasma supply for factor VIII production, be obtained within the frame of a blood component program? Scand J Haematol Suppl (1984) 0.75
Quantitative estimation of immunoglobulins on antibody-coated red cells. Bibl Haematol (1965) 0.75
International forum. What is the optimal storage temperature for whole blood prior to preparation of blood components. Vox Sang (1993) 0.75
Autologous transfusions in patients undergoing gastric surgery. Acta Chir Scand (1972) 0.75
Assessing a quality control program for erythrocyte preservation and attempts to improve quality of cells after storage at +4 degree C. Biomed Biochim Acta (1983) 0.75
[Great safety in Scandinavian blood handling]. Nord Med (1996) 0.75
Red-cell suspensions. N Engl J Med (1979) 0.75
[New methods for blood preservation]. Lakartidningen (1966) 0.75
The future use of pathogen-inactivated platelet concentrates. Vox Sang (2003) 0.75
Freezing of lymphocytes. Presentation of a new fully automated device and comparison between three methods. Vox Sang (1972) 0.75
Advances in blood transfusion. Rev Fr Transfus Immunohematol (1979) 0.75
Oxygen affinity of stored blood. Acta Anaesthesiol Scand Suppl (1971) 0.75
A national blood transfusion system integrating a central computer service with hospital-based minicomputer routines. Vox Sang (1981) 0.75
Lack of success with a combination of alanine and phosphoenolpyruvate as an additive for liquid storage of red cells at 4 degrees C. Transfusion (1990) 0.75
Transient neutrophil agranulocytosis in a newborn with leucocyte antibodies of type anti-8a in the mother. Acta Med Scand Suppl (1966) 0.75
Increased anticoagulant osmolality improves separation of leukocytes from red blood cells (RBC). Transfus Sci (1999) 0.75
A new allele (U18) in the HL-A system. Vox Sang (1973) 0.75
Substance rates of different steps of purine metabolism in normal and preserved red blood cells (RBC) studied in experiments simulating in vivo conditions. Adv Exp Med Biol (1984) 0.75
Effects of oxygen and mixing on red cells stored in plastic bags at +4 degrees C. Biomed Biochim Acta (1987) 0.75
[The introduction and use of the data technic for registration in the blood donor service]. Bibl Haematol (1969) 0.75
Phosphoenolpyruvate in the rejuvenation of stored red cells in SAGM medium: optimal conditions and the indirect effect of methemoglobin formation. Transfusion (1989) 0.75
Transfusion-associated Serratia marcescens infection: studies of the mechanism of action. Transfusion (1993) 0.75
Human histocompatibility matching. II. Calculated probability and clinical reality. Scand J Urol Nephrol (1974) 0.75
Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant. Vox Sang (1996) 0.75